CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,414 | $35.32 | $121K | 73,923 |
| 2025-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −7,689 | 15,379 | ||
| 2025-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,432 | 199,463 | ||
| 2025-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,300 | $35.32 | $117K | 196,163 |
| 2025-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,432 | 0 | ||
| 2025-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +9,694 | 196,188 | ||
| 2025-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −4,305 | $35.32 | $152K | 191,883 |
| 2025-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −9,694 | 0 | ||
| 2025-02-22 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise 10b5-1 | +3,114 | 10,831 | ||
| 2025-02-22 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes 10b5-1 | −983 | $35.32 | $35K | 9,848 |
| 2025-02-22 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award 10b5-1 | −3,114 | 0 | ||
| 2025-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +7,109 | 144,989 | ||
| 2025-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −3,154 | $35.32 | $111K | 141,835 |
| 2025-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −7,109 | 0 | ||
| 2025-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +7,109 | 89,463 | ||
| 2025-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −3,157 | $35.32 | $112K | 86,306 |
| 2025-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −7,109 | 0 | ||
| 2025-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +12,279 | 75,100 | ||
| 2025-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −5,452 | $35.32 | $193K | 69,648 |
| 2025-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −12,279 | 0 |
Page 16 of 41 · 804 trades